1. Home /
  2. Marijuana

Marijuana

Podcast: What Does the Cannabis Industry Have in Common with the Dot-Com?

Does the smoking cannabis industry share more than a few things in common with the Dot-com in the 1990s. Check out this podcast from the Real Money team.

Tilray CEO: Surging Cannabis Industry Is a Threat to Food and Drug Players

Tilray is full steam ahead in taking on some established players in the food and drug industry. CEO Brendan Kennedy discusses the company's efforts to grow.

How This Former VC Player Became CEO of $2 Billion Cannabis Company Tilray

Cannabis company Tilray is fresh off a smoking hot IPO this week. TheStreet talks with Tilray's CEO Brendan Kennedy about how he came to the cannabis industry.

Tilray CEO: IPO Marks the Mainstreaming of Cannabis Industry

Medicinal cannabis company Tilray saw a robust response to its IPO on the Nasdaq Thursday. TheStreet talks with Tilray's CEO Brendan Kennedy about the company's prospects.

REPLAY: Jim Cramer on Broadcom, CA, Johnson & Johnson, Citigroup & Canopy Growth

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Thursday's trending stocks from the floor of the New York Stock Exchange

Jim Cramer: Here's What You Need to Know About Canopy Growth's Stock

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer interviewed marijuana company Canopy Growth's CEO Bruce Linton.

It's Not Always Smooth Sailing for Cannabis Firms In Need of Capital, CEO Says

When a cannabis company needs money to fuel growth, it's never as simple as heading to the bank to shop investors.

Why Kiss Legend Gene Simmons Is Betting on Cannabis

Rock legend Gene Simmons is all in on cannabis despite being notoriously anti drugs and alcohol.

5 Cannabis Products You Never Knew You Needed

From dog treats to face wash, these are the next big thing in cannabis.

Weed Companies Need to 'End Prohibition' Before They Can List Shares in the U.S.

MedMen is now selling shares on the Canadian Securities Exchange. Here's why it still isn't possible for the $1.65 billion company to list in its home country.